Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc.
| Actelion Pharmaceuticals Ltd. |
| Mylan Pharmaceuticals Inc. |
| 1:2020cv00110 |
| June 9, 2020 |
| US District Court for the Northern District of West Virginia |
| Irene M Keeley |
| Patent - Abbreviated New Drug Applications (ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 14, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 5
VERIFICATION OF ATTORNEY ADMISSION to Attorneys Selikson, Wexler, Sperling and Ratliff. (mh)
|
|
Filing 4
Corporate Disclosure Statement by Actelion Pharmaceuticals Ltd. identifying Corporate Parent Johnson and Johnson for Actelion Pharmaceuticals Ltd... (Taylor, Chad)
|
|
Filing 2
REPORT to USPTO on the filing or determination of an action regarding re #1 Complaint. (mh)
|
|
Filing 1
COMPLAINT against Mylan Pharmaceuticals Inc., filed by Actelion Pharmaceuticals Ltd. Filing Fee $400. Receipt #0424-3054157. (Attachments: #1 Exhibit A - Patent Information, #2 Exhibit B - Patent Information, #3 Civil Cover Sheet)(mh)
|
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
